Back to search results

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Concord Repatriation General Hospital /ID# 201261, Concord, New South Wales, Australia

  • St George Hospital /ID# 206484, Kogarah, New South Wales, Australia

  • Monash Health - Monash Medical Centre /ID# 201263, Clayton, Victoria, Australia

  • Anhui Provincial Cancer Hospital /ID# 209458, Hefei, Anhui, China

  • Peking University People's Hospital /ID# 156575, Beijing, Beijing Municipality, China

  • Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 156576, Beijing, Beijing Municipality, China

  • Fujian Medical University Union Hospital /ID# 156579, Fuzhou, Fujian, China

  • Guangdong Provincial Peoples Hospital /ID# 160509, Guangzhou, Guangdong, China

  • Nanfang Hospital of Southern Medical University /ID# 156571, Guangzhou, Guangdong, China

  • The Second Hospital of Hebei Medical University /ID# 159143, Shijiazhuang, Hebei, China

  • Henan Cancer Hospital /ID# 156573, Zhengzhou, Henan, China

  • Tongji Hospital Tongji Medical College of HUST /ID# 156589, Wuhan, Hubei, China

  • Xiangya Hospital Central South University /ID# 208913, Changsha, Hunan, China

  • Jiangsu Province Hospital /ID# 156577, Nanjing, Jiangsu, China

  • The First Affiliated Hospital of Soochow University /ID# 156536, Suzhou, Jiangsu, China

  • The First Affiliated Hospital of Nanchang University /ID# 159142, Nanchang, Jiangxi, China

  • The First Hospital of Jilin University /ID# 156532, Changchun, Jilin, China

  • Shandong Provincial Hospital /ID# 156574, Jinan, Shandong, China

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 156572, Shanghai, Shanghai Municipality, China

  • West China Hospital, Sichuan University /ID# 156537, Chengdu, Sichuan, China

  • The General Hospital of Western Theater Command PLA /ID# 159145, Chengdu, Sichuan, China

  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 157762, Tianjin, Tianjin Municipality, China

  • Tianjin Medical University Cancer Institute & Hospital /ID# 156542, Tianjin, Tianjin Municipality, China

  • The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 156578, Hangzhou, Zhejiang, China

  • North Shore Hospital /ID# 204637, Takapuna, Auckland, New Zealand

  • Christchurch Hospital. /ID# 201650, Christchurch, Canterbury, New Zealand

  • National Taiwan University Hospital /ID# 210733, Taipei City, Taipei, Taiwan

  • Changhua Christian Hospital /ID# 202768, Changhua City, Changhua County, Taiwan

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 202765, Kaohsiung City, Taiwan

  • China Medical University Hospital /ID# 202767, Taichung, Taiwan

  • Linkou Chang Gung Memorial Hospital /ID# 203636, Taoyuan City, Taiwan

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)